Suppr超能文献

哪种选择性5-羟色胺再摄取抑制剂(SSRI)对青少年抑郁症的治疗效果最佳?

Which SSRIs most effectively treat depression in adolescents?

作者信息

DeLucia Valory, Kelsberg Gary, Safranek Sarah

机构信息

Valley Family Medicine Residency, University of Washington at Renton, WA, USA.

University of Washington Health Science Library, Seattle, WA, USA.

出版信息

J Fam Pract. 2016 Sep;65(9):632-4.

Abstract

We don't know which selective serotonin reuptake inhibitors (SSRIs) are the most effective and safe because no studies have compared these antidepressants with each other. Three SSRI antidepressant medications--fluoxetine, sertraline, and escitalopram--produce modest improvements (about 5% to 10%) in standardized depression scores without a significant increase in the risk of suicide-related outcomes (suicidal behavior or ideation) in adolescent patients with major depression of moderate severity.

摘要

我们不知道哪种选择性5-羟色胺再摄取抑制剂(SSRI)最为有效和安全,因为尚无研究对这些抗抑郁药进行相互比较。三种SSRI抗抑郁药物——氟西汀、舍曲林和艾司西酞普兰——在中度严重程度的青少年重度抑郁症患者中,可使标准化抑郁评分有适度改善(约5%至10%),且与自杀相关后果(自杀行为或想法)的风险无显著增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验